Cancer Research

What Is the True Cost of Medical Tourism?
Research & Development What Is the True Cost of Medical Tourism?

The promise of affordable elective surgery in an exotic location has captivated a growing number of patients, but a closer examination reveals a far more complex and costly reality hidden behind the glossy brochures and enticing online advertisements. This burgeoning global industry, built on the

New Blood Test Detects Cancer From Vague Symptoms
Research & Development New Blood Test Detects Cancer From Vague Symptoms

For countless patients experiencing persistent fatigue or unexplained pain, the journey toward a diagnosis is often a long and frustrating odyssey through the healthcare system. These non-specific symptoms, which can signal anything from a benign condition to a life-threatening malignancy, present

Could One Type of Fat Control Blood Pressure?
Research & Development Could One Type of Fat Control Blood Pressure?

The relentless global rise of hypertension has long been shadowed by its close companion, obesity, creating a public health crisis that has puzzled scientists and clinicians for decades. For years, the prevailing wisdom held that the sheer volume of body fat was the primary driver of high blood

A Gene May Hold the Key to Fighting Pancreatic Cancer
Research & Development A Gene May Hold the Key to Fighting Pancreatic Cancer

Within the vast and complex landscape of the human genome, a single, unassuming gene may be the silent guardian that stands between a healthy pancreas and one of the most lethal forms of cancer known to medicine. Researchers have now brought this potential protector, CTDNEP1, into the spotlight,

EU Female Lung Cancer Deaths Are Finally Leveling Off
Research & Development EU Female Lung Cancer Deaths Are Finally Leveling Off

For the first time in over a quarter-century, projections indicate a monumental shift in a public health crisis that has disproportionately affected European women, as the relentless rise in lung cancer mortality is finally showing signs of stabilizing. This development suggests a critical turning

New Study Reveals a Targetable Weakness in AML
Research & Development New Study Reveals a Targetable Weakness in AML

We sit down with Biopharma expert Ivan Kairatov to discuss a recent study that uncovers a critical vulnerability in acute myeloid leukemia (AML), a notoriously difficult-to-treat blood cancer. This research zeroes in on the survival mechanisms of resilient leukemia stem cells, identifying a key

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later